News

Google and Chevron have taken part in a $150 million funding round of TAE Technologies, which is developing a new type of nuclear fusion reactor ... due to the growth of AI and data centers.
SAN FRANCISCO, CA / ACCESS Newswire / June 4, 2025 / Sama, the leader in purpose-built, responsible enterprise AI with agile data labeling for model training and performance evaluation, today ...
SAN FRANCISCO, CA / ACCESS Newswire / June 4, 2025 / Sama, the leader in purpose-built, responsible enterprise AI with agile data labeling for model training and performance evaluation, today ...
Sama Multimodal offers enterprise AI teams a flexible framework and its widget-based architecture makes it easy to rapidly integrate multiple AI models at different stages of workflow, including ...
FuseLIP is a multimodal embedding architecture that unifies text and image inputs through early fusion. Unlike traditional contrastive models that use separate encoders and rely on late fusion, ...
Initial implementations have delivered 35% accuracy improvement and 10% reduction in product returns SAN FRANCISCO, CA / ACCESS Newswire / June 4, 2025 / Sama, the leader in purpose-built ...
SAN FRANCISCO, CA / ACCESS Newswire / June 4, 2025 / Sama, the leader in purpose-built, responsible enterprise AI with agile data labeling for model training and performance evaluation, today ...
SAN FRANCISCO, CA / ACCESS Newswire / June 4, 2025 / Sama, the leader in purpose-built, responsible enterprise AI with agile data labeling for model training and performance evaluation, today ...
The MCPF1412 from Microchip Technology is a high-efficiency, fully integrated point-of-load 12-A power module integrating a 16-V V IN buck converter and support for I2C and PMBus interfaces. Its ...
SAN FRANCISCO, CA / ACCESS Newswire / June 4, 2025 / Sama, the leader in purpose-built, responsible enterprise AI with agile data labeling for model training and performance evaluation, today ...
In this retrospective multimodal re-analysis of AstraZeneca’s Phase 3 POSEIDON trial (NCT03164616), AI-powered models were trained on integrated clinical trial data to predict treatment benefit.